JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

FABP4, GINS2 and CBX7 Expression in Cancer Cervix Tissues: Clinical, Pathological and Prognostic Implications

  • 0Department of Pathology, Zagazig University Faculty of Medicine, Zagazig, Egypt.
Iranian Journal of Pathology +

|

June 12, 2024

|

June 12, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

High expression of FABP4 and GINS2, and low expression of CBX7, are linked to advanced cervical cancer and recurrence. These biomarkers may help predict lymph node metastasis and guide preoperative treatment strategies.

Area Of Science

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background

  • Cervical cancer metastasis to pelvic lymph nodes leads to poor survival rates.
  • Early detection of lymph node status is crucial for effective cervical cancer treatment.
  • There is a need for novel predictive biomarkers for cervical cancer lymph node involvement.

Purpose Of The Study

  • To evaluate the expression of FABP4, GINS2, and CBX7 in cervical cancer tissues.
  • To determine the prognostic and predictive roles of these biomarkers in lymph node metastasis.
  • To assess the association between biomarker expression and clinicopathological parameters.

Main Methods

  • Immunohistochemistry was used to assess FABP4, GINS2, and CBX7 expression in cervical cancer tissues.
  • The study analyzed the correlation between biomarker expression and various clinicopathological and prognostic factors.
  • Tissue samples were collected from patients diagnosed with cervical cancer.

Main Results

  • High FABP4 and GINS2 expression and low CBX7 expression correlated with older age, larger tumor size, and advanced FIGO stage.
  • These expression patterns were also associated with lymphovascular invasion, parametrial infiltration, and chemotherapeutic resistance.
  • The findings indicated a link between biomarker expression and increased tumor recurrence.

Conclusions

  • FABP4 and GINS2 exhibit oncogenic roles, while CBX7 acts as a tumor suppressor in cervical cancer.
  • These biomarkers are associated with unfavorable clinicopathological features and poor survival outcomes.
  • FABP4, GINS2, and CBX7 show potential as preoperative predictive biomarkers for lymph node metastasis in cervical cancer, aiding in treatment planning.

Keywords: